Market Research Logo

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.

BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker's clients and projects are kept confidential.

...Show More ...Show Less

219 Reports from BioSeeker Group AB

   
  • Bispecific CD3 Molecules in Oncology: Analytical Tool

    ... expressed by the T-cell. Upon binding to both targets, these compounds redirect T-cell cytotoxicity toward the malignant cells and effectively eradicate them. Bispecific CD3 Molecules in Oncology: Analytical Tool is the most up to date ... Read More

  • Immuno-Oncology Drug Development: Analytical Tool

    ... current progress of immune-checkpoint inhibitors and CAR-T therapies to make the immune system fight cancer. Immuno-Oncology Drug Development: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available ... Read More

  • CAR/TCR Therapies in Oncology: Analytical Tool

    ... both Novartis and Kite Pharma (now Gilead Sciences) for being the first companies to bring these novel therapies to market with Kymriah (tisagenlecleucel-t) and Yescarta (axicabtagene ciloleucel) respectively. CAR/TCR Therapies in Oncology: Analytical Tool is ... Read More

  • Epigenetic Therapies in Oncology: Analytical Tool

    ... under development and entering clinical trials. Epigenetic Therapies in Oncology: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in ... Read More

  • DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool

    ... DDR deficiencies to preferentially kill cancer cells, while minimizing the impact on normal cells, has potential for more selective, better tolerated therapies to improve survival in multiple cancers. DNA Damage Response (DDR) Drugs in Oncology: ... Read More

  • Bispecific Molecules in Oncology: Analytical Tool

    ... tumor-targeted immunomodulators; and (II) dual immunomodulators. Bispecific Molecules in Oncology: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in ... Read More

  • Commercial Interest at ESMO Annual Meeting 2018: Analytical Tool

    ... from the European Society of Medical Oncology (ESMO 2017) congress. Similar in scope to it's American cousin ASCO, this conference features more than 2000 abstracts detailing the latest ground-breaking science and in this too we ... Read More

  • Immune-checkpoint Drugs in Oncology: Analytical Tool

    ... changed the possibility to harness the power of the immune system in fighting cancer not only as a monotherapy but, maybe more importantly, also as a combination therapy. Immune-checkpoint Drugs in Oncology: Analytical Tool is ... Read More

  • Oncolytic Virotherapies: Analytical Tool

    ... limited clinical efficacy as a single agent and therefore they are often being investigated in the combination with other forms of cancer therapy, including immune checkpoint inhibition. Oncolytic Virotherapies: Analytical Tool is the most up ... Read More

  • Targeting the CD47-SIRPA Axis in Oncology: A Competitive Assessment of Technologies, Dual Targeting, Biomarkers, Combination Therapies & More

    ... seeking to target innate immune response. This report reveals intense global interest and a growing list of stakeholders operating in this field. Users of this report get an un-biased, fact driven analysis of the position ... Read More

  • Commercial Interests at ASCO 2017 - A 1stOncology Insights Report

    ... American Society of Clinical Oncology (ASCO) Annual Meeting 2017. Break through the mountain of close 5,000 abstracts presented at ASCO 2017 with a focused entry to reveal the identity and position of more than 470 ... Read More

  • Commercial Interests at ASGCT 2017 - A 1stOncology Insights Report

    ... American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2017. Break through the mountain of almost one thousand abstracts presented at ASGCT 2017 with a focused entry to reveal the identity and position of ... Read More

  • Commercial Interests at AACR 2017 - A 1stOncology Insights Report

    ... Meeting. This leading event in the oncology drug developers calender represents some of the very best in cancer science and this report allows the reader to review the meeting through the lens of 17 “hot” ... Read More

  • Finding and Evaluating Oncology Opportunities at BIO Asia 2017- A 1stOncology Insights Report

    ... must read for anyone with an interest in oncology at this exclusive partnering forum. This report features the oncology position and activities of 61 companies identified by the analyst team at 1stOncology™. This provides you ... Read More

  • Melanoma: Analytical Tool

    ... drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion Diagnostic ... Read More

  • Breast Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Cancer Vaccines: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Leukemia: Analytical Tool

    ... drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion Diagnostic ... Read More

  • Prostate Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Cancer Immunotherapy: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Lung Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Hematological Cancers: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Pancreatic Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Renal Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Liver Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

< prev 1 3 4 5 6 7 8 9

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook